|
|
|
|
| |||||||||||||||||||||||||||||||||||||||||||||||||||||
Received for publication March 7, 2008.
Revised July 30, 2008.
Accepted for publication July 31, 2008.
The aryl hydrocarbon receptor associated protein-9 (ARA9) is a chaperone of the aryl hydrocarbon receptor (AHR). The AHR has been shown to play a late developmental role in the normal closure of a fetal hepato-vascular shunt known as the ductus venosus (DV). Given that Ara9 null mice display early embryonic lethality, we generated a hypomorphic Ara9 allele (designated Ara9fxneo) that displays reduced ARA9 protein expression. In an effort to demonstrate the role of ARA9 protein in AHR-mediated DV closure, we used combinations of Ara9 wildtype (Ara9+/+), null (Ara9-/-) and hypomorphic (Ara9fxneo) alleles to produce mice with a graded expression of the ARA9 protein. Liver perfusion studies demonstrated that while none of the Ara9+/+ mice displayed a patent DV, the shunt was observed in 10% of the Ara9+/fxneo mice, 55% of the Ara9+/+ mice and 83% of the Ara9fxneo/fxneo mice. That expression level of ARA9 correlates with the frequency of a phenocopy of the Ahr null allele supports the conclusion that the ARA9 protein is essential for AHR signaling during development.
Key words:
Cytochrome P450, Ah receptor, Toxicant-induced gene express